Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
Abstract Background Preclinical evidence from us and others demonstrates that the anticancer effects of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors can be enhanced with focal radiation therapy (RT), but only when RT is delivered prior to (rather than after) CDK4/6 inhibition. Depending on tumor...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2023-02-01
|
| Edice: | Journal of Translational Medicine |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12967-023-03964-4 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
